Three Dimensional Structure of Kringle Domain
暂无分享,去创建一个
[1] E. Perens,et al. A C. elegans Ror receptor tyrosine kinase regulates cell motility and asymmetric cell division , 1999, Nature.
[2] T. L. Moser,et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] O. Klezovitch,et al. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. , 1999, Biochemistry.
[4] N. Ip,et al. Xenopus muscle‐specific kinase: molecular cloning and prominent expression in neural tissues during early embryonic development , 1999, The European journal of neuroscience.
[5] M. Llinás,et al. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] T. Rhim,et al. Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth. , 1998, Biochemical and biophysical research communications.
[7] M. Ultsch,et al. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution. , 1998, Structure.
[8] M. Llinás,et al. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. , 1998, Biochemical and biophysical research communications.
[9] A. Tulinsky,et al. Localization of the Thrombin-binding Domain on Prothrombin Fragment 2* , 1998, The Journal of Biological Chemistry.
[10] A. Tulinsky,et al. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. , 1998, Biochemistry.
[11] Y. Kamikubo,et al. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells , 1998, FEBS letters.
[12] P. Sonderegger,et al. Neurotrypsin, a Novel Multidomain Serine Protease Expressed in the Nervous System , 1997, Molecular and Cellular Neuroscience.
[13] C. Esmon,et al. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. , 1997, Structure.
[14] N. Yamaguchi,et al. Molecular cloning of a novel brain-specific serine protease with a kringle-like structure and three scavenger receptor cysteine-rich motifs. , 1997, Biochemical and biophysical research communications.
[15] M. Llinás,et al. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR. , 1997, Biochemistry.
[16] Y. Nishida,et al. A Novel Drosophila Receptor Tyrosine Kinase Expressed Specifically in the Nervous System , 1997, The Journal of Biological Chemistry.
[17] J. Nishioka,et al. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex. , 1997, The Biochemical journal.
[18] J. Folkman,et al. Kringle Domains of Human Angiostatin , 1996, The Journal of Biological Chemistry.
[19] T. Tobe,et al. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. , 1996, Journal of biochemistry.
[20] A. Tulinsky,et al. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid. , 1996, Biochemistry.
[21] K. Kotkow,et al. The Second Kringle Domain of Prothrombin Promotes Factor Va- mediated Prothrombin Activation by Prothrombinase (*) , 1995, The Journal of Biological Chemistry.
[22] F. Castellino,et al. Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands. , 1994, The Journal of biological chemistry.
[23] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[24] T. Gojobori,et al. Molecular evolution of serine protease and its inhibitor with special reference to domain evolution. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[25] A. Tulinsky,et al. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. , 1994, Biochemistry.
[26] H. Steller,et al. Dror, a potential neurotrophic receptor gene, encodes a Drosophila homolog of the vertebrate Ror family of Trk-related receptor tyrosine kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] N. Yuhki,et al. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. , 1993, The Journal of biological chemistry.
[28] K. Miyazawa,et al. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. , 1993, The Journal of biological chemistry.
[29] S. Burden,et al. Muscle-specific trk-related receptor with a kringle domain defines a distinct class of receptor tyrosine kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Masiakowski,et al. A novel family of cell surface receptors with tyrosine kinase-like domain. , 1992, The Journal of biological chemistry.
[31] M. Ultsch,et al. Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. , 1992, Biochemistry.
[32] M. Llinás,et al. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. , 1991, Journal of molecular biology.
[33] A. Tulinsky,et al. Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution. , 1991, Biochemistry.
[34] A. Tulinsky,et al. The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4. , 1991, Biochemistry.
[35] J. Mimuro,et al. The plasminogen activator inhibitor-1 binding site in the kringle-2 domain of tissue-type plasminogen activator. , 1991, Biochemical and biophysical research communications.
[36] A. Tulinsky,et al. Structure of bovine prothrombin fragment 1 refined at 2.25 A resolution. , 1991, Journal of molecular biology.
[37] D. Botstein,et al. High resolution analysis of functional determinants on human tissue-type plasminogen activator. , 1991, The Journal of biological chemistry.
[38] H. Wu,et al. Interaction of plasminogen and fibrin in plasminogen activation. , 1990, The Journal of biological chemistry.
[39] K. Constantine,et al. Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy. , 1990, The Journal of biological chemistry.
[40] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[41] L. Duong,et al. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator. , 1989, The Journal of biological chemistry.
[42] A. Tulinsky,et al. Structure of prothrombin fragment 1 refined at 2.8 A resolution. , 1988, Journal of molecular biology.
[43] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[44] A. Tulinsky,et al. Three-dimensional structure of the kringle sequence: structure of prothrombin fragment 1. , 1986, Biochemistry.
[45] M. Kline,et al. The effect of bovine thrombomodulin on the specificity of bovine thrombin. , 1986, The Journal of biological chemistry.
[46] K Fujikawa,et al. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor). , 1985, The Journal of biological chemistry.
[47] P. Seeburg,et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.
[48] L. Flohé,et al. The complete amino acid sequence of low molecular mass urokinase from human urine. , 1982, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[49] Z. Váli,et al. Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4. , 1982, The Journal of biological chemistry.
[50] Z. Váli,et al. Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen. , 1982, The Journal of biological chemistry.
[51] P. Lerch,et al. Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. , 1980, European journal of biochemistry.
[52] C. Esmon,et al. The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III. , 1979, The Journal of biological chemistry.
[53] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.
[54] A. Tulinsky,et al. Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin , 1988, Proteins.